Takeda Pharmaceutical Company Limited (TYO: 4502)
4,263.00
-8.00 (-0.19%)
Sep 9, 2024, 3:15 PM JST
Takeda Pharmaceutical Company Revenue
Takeda Pharmaceutical Company had revenue of 1.21T JPY in the quarter ending June 30, 2024, with 14.11% growth. This brings the company's revenue in the last twelve months to 4.41T, up 7.28% year-over-year. In the fiscal year ending March 31, 2024, Takeda Pharmaceutical Company had annual revenue of 4.26T with 5.87% growth.
Revenue (ttm)
4,413.13B
Revenue Growth
+7.28%
P/S Ratio
1.51
Revenue / Employee
89.55M
Employees
49,281
Market Cap
6,756.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4,263.76B | 236.28B | 5.87% |
Mar 31, 2023 | 4,027.48B | 458.47B | 12.85% |
Mar 31, 2022 | 3,569.01B | 371.19B | 11.61% |
Mar 31, 2021 | 3,197.81B | -93.38B | -2.84% |
Mar 31, 2020 | 3,291.19B | 1,193.96B | 56.93% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTakeda Pharmaceutical Company News
- 4 days ago - U.S. allows ADHD drugmaker to increase production limit to ease ongoing shortage - NBC News
- 5 days ago - US allows increased production of Takeda's ADHD drug to address shortage - Reuters
- 10 days ago - Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry - Benzinga
- 11 days ago - Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry - Benzinga
- 21 days ago - Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer - Benzinga
- 25 days ago - In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry - Benzinga
- 27 days ago - Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues - Benzinga
- 4 weeks ago - Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday? - Benzinga